サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1318717

ウイルスベクター市場：タイプ別、疾患別、用途別、エンドユーザー別-2023-2030年の世界予測

Viral Vectors Market by Type, Disease, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ウイルスベクター市場：タイプ別、疾患別、用途別、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ウイルスベクターの世界市場は大きく成長し、2023年には16億6,279万米ドル、CAGR14.02%と予測され、2030年には41億8,389万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のウイルスベクター市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ウイルスベクターの世界市場規模および予測は？

2.予測期間中、世界のウイルスベクター市場を形成するCOVID-19の阻害要因と影響は？

3.ウイルスベクターの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.ウイルスベクターの世界市場における競争戦略は？

5.ウイルスベクターの世界市場における技術動向と規制の枠組みは？

6.ウイルスベクターの世界市場における主要ベンダーの市場シェアは？

7.ウイルスベクターの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • さまざまな感染症やウイルスに対するワクチンの増産
      • 対象となる病気や病気の蔓延の増加
      • 細胞治療および遺伝子治療に対する政府の取り組み
    • 抑制要因
      • 高額な遺伝子・細胞療法治療
    • 機会
      • 希少疾患治療法における研究開発が進行中
      • 大規模な受託開発および製造組織による投資
    • 課題
      • 挿入突然変異誘発と免疫反応のリスク
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 ウイルスベクター市場：タイプ別

  • アデノ関連ウイルスベクター
  • アデノウイルスベクター
  • レトロウイルスベクター

第7章 ウイルスベクター市場：疾患別

  • がん
  • 遺伝性疾患
  • 感染症

第8章 ウイルスベクター市場：用途別

  • 遺伝子治療
  • ワクチン学

第9章 ウイルスベクター市場：エンドユーザー別

  • 製薬会社およびバイオ医薬品会社
  • 調査機関

第10章 南北アメリカのウイルスベクター市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のウイルスベクター市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのウイルスベクター市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. VIRAL VECTORS MARKET RESEARCH PROCESS
  • FIGURE 2. VIRAL VECTORS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. VIRAL VECTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VIRAL VECTORS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. VIRAL VECTORS MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
  • FIGURE 6. VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. VIRAL VECTORS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 8. VIRAL VECTORS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. VIRAL VECTORS MARKET DYNAMICS
  • FIGURE 10. VIRAL VECTORS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. VIRAL VECTORS MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. VIRAL VECTORS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES VIRAL VECTORS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. VIRAL VECTORS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. VIRAL VECTORS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. VIRAL VECTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. VIRAL VECTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. VIRAL VECTORS MARKET SIZE, BY ADENO-ASSOCIATED VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. VIRAL VECTORS MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VIRAL VECTORS MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 9. VIRAL VECTORS MARKET SIZE, BY CANCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VIRAL VECTORS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. VIRAL VECTORS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. VIRAL VECTORS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. VIRAL VECTORS MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. VIRAL VECTORS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. VIRAL VECTORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES VIRAL VECTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. VIRAL VECTORS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 187. VIRAL VECTORS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 188. VIRAL VECTORS MARKET LICENSE & PRICING
目次
Product Code: MRR-957C47F9407A

The Global Viral Vectors Market is forecasted to grow significantly, with a projected USD 1,662.79 million in 2023 at a CAGR of 14.02% and expected to reach a staggering USD 4,183.89 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Viral Vectors Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Viral Vectors Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Adeno-associated Viral Vectors, Adenoviral Vectors, and Retroviral Vectors. The Adeno-associated Viral Vectors is projected to witness significant market share during forecast period.

Based on Disease, market is studied across Cancers, Genetic Disorders, and Infectious Diseases. The Infectious Diseases is projected to witness significant market share during forecast period.

Based on Application, market is studied across Gene Therapy and Vaccinology. The Gene Therapy is projected to witness significant market share during forecast period.

Based on End User, market is studied across Pharmaceutical & Biopharmaceutical Companies and Research Institutes. The Pharmaceutical & Biopharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Viral Vectors Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Viral Vectors Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viral Vectors Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viral Vectors Market?

4. What is the competitive strategic window for opportunities in the Global Viral Vectors Market?

5. What are the technology trends and regulatory frameworks in the Global Viral Vectors Market?

6. What is the market share of the leading vendors in the Global Viral Vectors Market?

7. What modes and strategic moves are considered suitable for entering the Global Viral Vectors Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Viral Vectors Market, by Type, 2022 vs 2030
  • 4.3. Viral Vectors Market, by Disease, 2022 vs 2030
  • 4.4. Viral Vectors Market, by Application, 2022 vs 2030
  • 4.5. Viral Vectors Market, by End User, 2022 vs 2030
  • 4.6. Viral Vectors Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing vaccine production for various infections and viruses
      • 5.1.1.2. Growing prevalence of target ailments and diseases
      • 5.1.1.3. Government initiatives for cell and gene therapy treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of gene & cell therapy treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development in rare disease treatments
      • 5.1.3.2. Investments by large contract development and manufacturing organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of insertional mutagenesis and immune response
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Viral Vectors Market, by Type

  • 6.1. Introduction
  • 6.2. Adeno-associated Viral Vectors
  • 6.3. Adenoviral Vectors
  • 6.4. Retroviral Vectors

7. Viral Vectors Market, by Disease

  • 7.1. Introduction
  • 7.2. Cancers
  • 7.3. Genetic Disorders
  • 7.4. Infectious Diseases

8. Viral Vectors Market, by Application

  • 8.1. Introduction
  • 8.2. Gene Therapy
  • 8.3. Vaccinology

9. Viral Vectors Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biopharmaceutical Companies
  • 9.3. Research Institutes

10. Americas Viral Vectors Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Viral Vectors Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Viral Vectors Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing